The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.00
Bid: 540.00
Ask: 543.00
Change: 2.00 (0.37%)
Spread: 3.00 (0.556%)
Open: 533.00
High: 549.00
Low: 532.00
Prev. Close: 536.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Jan 2018 14:57

RNS Number : 3052C
Polar Capital Holdings PLC
18 January 2018
 

 

18 January 2018

 

Polar Capital Holdings plc ("Polar Capital" or the "Group")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

 

On 17 January 2018 Mr Tim Woolley, Non-Executive Director, exercised 227,365 share options under Polar Capital's 2007 Equity Inventive Plan (the "Plan"). Polar Capital has issued 163,720 Ordinary Shares in satisfaction of the options, all of which were then sold at a market price of 518p per Ordinary Share.

 

Mr Woolley no longer holds any share options under the Plan. He continues to hold shares as follows:

 

Ordinary Shares

5,000,000 Ordinary Shares representing approximately 5.36% of the Group's issued share capital.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Tim Woolley

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polar Capital Holdings plc

b)

 

LEI

 

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

 

 

Identification code

GB00B1GCLT25

 

 

b)

 

Nature of the transaction

 

 

Exercise of Share Options under the Equity Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

145.00 pence

227,365

 

 

 

 

 

 

 

d)

 

Aggregated information

Single transaction as in 4 c) above

 

 

- Aggregated volume

227,365

 

 

- Price

145.00 pence

 

 

 

e)

 

Date of the transaction

 

 

17-01-2018

f)

 

Place of the transaction

 

 

Off-Market

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

 

 

Identification code

GB00B1GCLT25

 

 

b)

 

Nature of the transaction

 

 

Sale of Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

518.00 pence

163,720

 

 

 

 

 

 

 

d)

 

Aggregated information

Single transaction as in 4 c) above

 

 

- Aggregated volume

163,720

 

 

- Price

518.00 pence

 

 

 

e)

 

Date of the transaction

 

 

17-01-2018

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM, XLON

 

 

The Group was also notified on 17 January 2018 that Mr Brian Ashford-Russell, a Non-Executive Director of Polar Capital, sold 375,000 Ordinary Shares from his personal holding at 518.00p per share. Following this transaction Mr Ashford-Russell is interested in a total of 5,450,000 Ordinary Shares representing approximately 5.84% of the Group's issued share capital. This holding consists of the following:

 

Prior to Transaction After Transaction

No. of Shares % Voting Rights No. of Shares % Voting Rights

Brian Ashford-Russell 4,775,000 5.14% 4,400,000 4.71%

Fenella Ashford Russell 800,000 0.86% 800,000 0.86%

ADFAL Trust 250,000 0.27% 250,000 0.27%

Total 5,825,000 6.27% 5,450,000 5.84%

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Brian Ashford-Russell

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polar Capital Holdings plc

b)

 

LEI

 

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

 

 

Identification code

GB00B1GCLT25

 

 

b)

 

Nature of the transaction

 

 

Sale of Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

518.00 pence

375,000

 

 

 

 

 

 

 

d)

 

Aggregated information

Single transaction as in 4 c) above

 

 

- Aggregated volume

375,000

 

 

- Price

518 pence

 

 

 

e)

 

Date of the transaction

 

 

17-01-2018

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM, XLON 

 

 

 

Enquiries:

 

Polar Capital

John Mansell / Neil Taylor

+44 (0)207 227 2700

 

Canaccord Genuity (Nomad and Joint Broker)

Simon Bridges / Andrew Buchanan

+44 (0)207 523 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZVLFFVFFEBBE
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.